Adaptyv Raises €34M for Agentic Biology
Lausanne-based Adaptyv raised €34.35M to build an automated wet lab for AI-driven protein design.
AI biology is running into a very physical bottleneck: experiments still have to happen in the lab.
What happened
Lausanne-based Adaptyv Bio raised a €34.35M Series A to build an automated wet lab for AI-driven protein design.
The company is focused on connecting AI design systems with real experimental testing, so candidate proteins can be generated, tested and refined faster than in traditional lab workflows.
Why it matters
This is a strong AI-biology infrastructure story. Many AI biotech companies can propose molecules or proteins, but the real constraint is validation: proving that designs work in the messy physical world.
Automated wet labs can become the feedback loop between model predictions and biological reality. That makes them valuable infrastructure for drug discovery, industrial biology and synthetic biology.
The bigger picture
The next wave of AI science companies may be judged less by model demos and more by experimental throughput.
If platforms like Adaptyv can make lab testing faster and cheaper, they could help biology move closer to an engineering discipline: design, test, learn and repeat at software-like speed.